OR AKIVA, Israel, September 30 /PRNewswire/ -- ITGI Medical, Ltd. (TASE: ITGI) a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents, announced that its second heterologous tissue covered stent - AneuGraft(R) received CE Mark approval.
AneuGraft(R) is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations in tortuous vessels.
"AneuGraft(R) Pericardium Covered Stent is especially suitable for patients with tortuous vessels where other covered stents may not be adequate for use due to limitations resulting from tortuous anatomy," says Efri Argaman ITGI Medical CEO.